Package 49702-212-48

Brand: retrovir

Generic: zidovudine
NDC Package

Package Facts

Identity

Package NDC 49702-212-48
Digits Only 4970221248
Product NDC 49702-212
Product ID 49702-212_01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a
Description

240 mL in 1 BOTTLE (49702-212-48)

Marketing

Marketing Status
Marketed Since 2010-10-28
Brand retrovir
Generic zidovudine
Sample Package No

Linked Drug Pages (1)

RETROVIR ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a", "openfda": {"nui": ["N0000175462", "N0000009947"], "upc": ["0349702211209"], "unii": ["4B9XT59T7S"], "rxcui": ["108396", "198352", "201907", "204534", "755298", "756209"], "spl_set_id": ["6df09f15-b102-431c-adde-d7aeef6f5d84"], "pharm_class_epc": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]"], "pharm_class_moa": ["Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "manufacturer_name": ["ViiV Healthcare Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "240 mL in 1 BOTTLE (49702-212-48)", "package_ndc": "49702-212-48", "marketing_start_date": "20101028"}], "brand_name": "RETROVIR", "product_id": "49702-212_01ba4f9b-3d72-4bc2-bae1-ecb13a8b845a", "dosage_form": "SOLUTION", "pharm_class": ["Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]"], "product_ndc": "49702-212", "generic_name": "zidovudine", "labeler_name": "ViiV Healthcare Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RETROVIR", "active_ingredients": [{"name": "ZIDOVUDINE", "strength": "10 mg/mL"}], "application_number": "NDA019910", "marketing_category": "NDA", "marketing_start_date": "20101028", "listing_expiration_date": "20261231"}